Reagan Jarvis

Company: Anocca

Job title: CEO

Seminars:

Engineered Cell Platforms For Profiling Off-Target TCR Allo- Reactivity And Cross-Reactivity 5:00 pm

Precise characterization of TCR off-target activity is critical to success of TCR-based cellular therapies Utilization of engineered cell platforms as analytical tools enables high-precision characterization of allo-reactivity and cross-reactivity phenomena Anocca’s assay technologies reveal fundamental insights into molecular basis of allo- and cross- reactivityRead more

day: Day One

Industry Leaders Fireside Chat – What Does the Future Hold for TCR therapies? 10:30 am

The hotly anticipated Industry Leader’s Fireside Chat will discuss the huge progress being made in the TCR therapeutic space. This session will explore the lessons we can takes from CAR-T, and will shed clarity on the priorities of the trailblazing companies in this field, whilst also touching upon the challenges faced with manufacturing costs, and…Read more

day: Day One